NapiFeryn BioTech

Łodz, Poland Founded: 2014 • Age: 12 yrs
Food-grade proteins from rapeseed are developed and supplied as ingredients.

About NapiFeryn BioTech

NapiFeryn BioTech is a company based in Łodz (Poland) founded in 2014 by Magdalena Kozlowska and Piotr Wnukowski.. NapiFeryn BioTech has raised $2.99 million across 8 funding rounds from investors including European Union, Icos Capital and EIC Fund. NapiFeryn BioTech offers products and services including Rapeseed Protein.

  • Headquarter Łodz, Poland
  • Founders Magdalena Kozlowska, Piotr Wnukowski
  • Sectors
    Consumer
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Napiferyn Biotech Spółka Z Ograniczoną Odpowiedzialnością
Operational Areas
Consumer → Food & Beverage
Consumer → Food, Beverage & Nutrition
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.99 M (USD)

    in 8 rounds

  • Latest Funding Round
    $139.84 K (USD), Grant

    May 01, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NapiFeryn BioTech

NapiFeryn BioTech offers a comprehensive portfolio of products and services, including Rapeseed Protein. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Extracts protein from rapeseed byproducts for sustainable food and nutrition uses.

Funding Insights of NapiFeryn BioTech

NapiFeryn BioTech has successfully raised a total of $2.99M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $139.84 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Grant — $139,835
  • First Round

    (01 Oct 2015)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Grant - NapiFeryn BioTech Valuation

investors

Feb, 2023 Amount Seed - NapiFeryn BioTech Valuation Icos Capital
Sep, 2022 Amount Grant - NapiFeryn BioTech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in NapiFeryn BioTech

NapiFeryn BioTech has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Icos Capital and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Icos Capital is focused on sustainability through technology investments.
Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Venture capital investments in innovative R&D projects are managed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by NapiFeryn BioTech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - NapiFeryn BioTech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Napiferyn Biotech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NapiFeryn BioTech

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Napiferyn Biotech

Frequently Asked Questions about NapiFeryn BioTech

When was NapiFeryn BioTech founded?

NapiFeryn BioTech was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is NapiFeryn BioTech located?

NapiFeryn BioTech is headquartered in Łodz, Poland. It is registered at Łodz, Łodz Voivodeship, Poland.

Who is the current CEO of NapiFeryn BioTech?

Magdalena Kozlowska is the current CEO of NapiFeryn BioTech. They have also founded this company.

Is NapiFeryn BioTech a funded company?

NapiFeryn BioTech is a funded company, having raised a total of $2.99M across 8 funding rounds to date. The company's 1st funding round was a Grant of $59.67K, raised on Oct 01, 2015.

What does NapiFeryn BioTech do?

NapiFeryn BioTech was founded in 2014 in Lodz, Poland, within the biotech sector. Patented technology has been developed to extract food-grade proteins from oilseeds, particularly rapeseed. These proteins exhibit varied functional properties, enabling their use as ingredients in food applications. Operations center on sustainable protein production from plant sources, supporting the food industry with reliable alternatives.

What products or services does NapiFeryn BioTech offer?

NapiFeryn BioTech offers Rapeseed Protein.

Who are NapiFeryn BioTech's investors?

NapiFeryn BioTech has 4 investors. Key investors include European Union, Icos Capital, EIC Fund, and Impera Alfa.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available